Abnormalities of elastin and elastic fibers in infantile hypertrophic pyloric stenosis. 1999

T Oue, and P Puri
Children's Research Centre, Our Lady's Hospital for Sick Children, Crumlin, Dublin, Ireland.

Infantile hypertrophic pyloric stenosis (IHPS) is characterized by hypertrophy of the pyloric muscle, causing pyloric-channel narrowing and elongation. The rigidity of the muscle is increased, which is characterized as an "olive." Elastin is an insoluble protein that forms the major structural component of the elastic fibers and maintains the tensile strength of the tissues. To understand the possible histologic and molecular basis of the elasticity of the hypertrophic muscle in IHPS, we determined the distribution of the elastic fibers and elastin expression using Victoria blue van Gieson (VVG) staining and immunohistochemistry. In IHPS, the number of elastic fibers in the connective tissue was significantly increased in the thickened connective-tissue septa (CTS) compared with normal control specimens. In normal pyloric muscle, weak to moderate elastin immunoreactivity was observed in the CTS while no immunoreactivity was observed among the muscle fibers. In IHPS, strong immunoreactivity of elastin was observed in the CTS and moderate immunoreactivity among the hypertrophic smooth-muscle fibers. Our findings suggest that the increase on elastic fibers and elastin expression in the pyloric muscle in IHPS may play an important role in the development of pyloric-muscle rigidity, causing pyloric-canal obstruction.

UI MeSH Term Description Entries
D006984 Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). Hypertrophies
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011707 Pyloric Stenosis Narrowing of the pyloric canal with varied etiology. A common form is due to muscle hypertrophy (PYLORIC STENOSIS, HYPERTROPHIC) seen in infants. Pyloric Obstruction,Pylorus Obstruction,Stenosis, Pyloric,Obstruction, Pyloric,Obstruction, Pylorus,Pyloric Obstructions,Pylorus Obstructions
D004548 Elasticity Resistance and recovery from distortion of shape.
D004549 Elastin alpha-Elastin,kappa-Elastin,alpha Elastin,kappa Elastin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Oue, and P Puri
January 1992, Digestive diseases (Basel, Switzerland),
T Oue, and P Puri
September 1990, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
T Oue, and P Puri
November 1965, Surgery,
T Oue, and P Puri
May 1986, Irish medical journal,
T Oue, and P Puri
May 1986, Irish medical journal,
T Oue, and P Puri
September 1966, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
T Oue, and P Puri
May 1977, Nursing times,
T Oue, and P Puri
July 1981, Scottish medical journal,
T Oue, and P Puri
May 2003, Radiology,
Copied contents to your clipboard!